Alternating Electric Fields (TTFields) Activate Ca(v)1.2 Channels in Human Glioblastoma Cells

Tumor treating fields (TTFields) represent a novel FDA-approved treatment modality for patients with newly diagnosed or recurrent glioblastoma multiforme. This therapy applies intermediate frequency alternating electric fields with low intensity to the tumor volume by the use of non-invasive transdu...

Descripción completa

Detalles Bibliográficos
Autores principales: Neuhaus, Eric, Zirjacks, Lisa, Ganser, Katrin, Klumpp, Lukas, Schüler, Uwe, Zips, Daniel, Eckert, Franziska, Huber, Stephan M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356873/
https://www.ncbi.nlm.nih.gov/pubmed/30669316
http://dx.doi.org/10.3390/cancers11010110

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356873/
https://www.ncbi.nlm.nih.gov/pubmed/30669316
http://dx.doi.org/10.3390/cancers11010110

Ejemplares similares